Business Context and Reporting Period
Company: Onto Innovation Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 27, 2025
Event: Entry into a Material Definitive Agreement to acquire Semilab USA LLC.
Key Financial Metrics and Transaction Terms
This filing details a specific acquisition transaction rather than periodic financial performance. Key transaction metrics include:
- Total Consideration: $475,000,000 in cash (subject to customary purchase price adjustments) plus 706,215 shares of Onto Innovation Inc. common stock.
- Target: Semilab USA LLC (all outstanding membership interests).
- Expected Closing: Second half of 2025.
- Revenue/Profit/Cash Flow: The filing text does not provide current period revenue, profit, cash flow, margins, debt, or liquidity figures for Onto Innovation Inc. or Semilab USA.
Material Changes and Transaction Conditions
The primary material change is the agreement to acquire Semilab USA. The transaction is subject to the following closing conditions:
- Expiration or termination of waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.
- Receipt of Hungarian foreign direct investment approval.
- Absence of any governmental order preventing consummation.
- Accuracy of representations and warranties and compliance with covenants.
- Absence of a Material Adverse Effect (as defined in the agreement).
The agreement includes termination rights if the transaction is not consummated within nine months (subject to a three-month extension) or if a governmental authority permanently enjoins the transaction.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release on June 30, 2025, announcing the agreement. The filing includes standard forward-looking statements regarding business momentum, market opportunities, and the anticipated benefits of the transaction.
Risks and Contingencies:
- Regulatory Risk: Potential prohibition, delay, or refusal of regulatory approvals (U.S. and Hungarian).
- Integration Risk: Difficulties in integrating the acquired business, achieving synergies, or retaining key personnel and customers.
- Market Risk: Fluctuations in semiconductor capital spending, supply chain disruptions, and geopolitical uncertainty.
- Termination Risk: The transaction may not be completed in the expected timeframe or at all.
Investor Verification Checklist
- Verify the status of Hart-Scott-Rodino and Hungarian foreign direct investment approvals.
- Review the full text of the Equity Purchase Agreement (Exhibit 2.1) for specific purchase price adjustment mechanisms and termination fees.
- Monitor for any Material Adverse Effect events that could trigger termination rights.
- Assess the dilution impact of the issuance of 706,215 shares of common stock.
- Confirm the expected closing date remains in the second half of 2025.